Impact of Glomerular Filtration Rate on the Incidence and Prognosis of New-Onset Atrial Fibrillation in Acute Myocardial Infarction.

acute myocardial infarction atrial fibrillation mortality renal function

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
09 May 2020
Historique:
received: 19 04 2020
revised: 04 05 2020
accepted: 05 05 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 14 5 2020
Statut: epublish

Résumé

Atrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI) and is associated with a worse prognosis. Patients with chronic kidney disease are more likely to develop AF. Whether the association between AF and glomerular filtration rate (GFR) is also true in AMI has never been investigated. We prospectively enrolled 2445 AMI patients. New-onset AF was recorded during hospitalization. Estimated GFR was estimated at admission, and patients were grouped according to their GFR (group 1 ( The AF incidence in the population was 10%, and it was 8%, 16%, 24% in groups 1, 2, 3, respectively ( This study demonstrates that new-onset AF incidence during AMI, as well as the associated in-hospital and long-term mortality, increases in parallel with GFR reduction assessed at admission.

Sections du résumé

BACKGROUND BACKGROUND
Atrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI) and is associated with a worse prognosis. Patients with chronic kidney disease are more likely to develop AF. Whether the association between AF and glomerular filtration rate (GFR) is also true in AMI has never been investigated.
METHODS METHODS
We prospectively enrolled 2445 AMI patients. New-onset AF was recorded during hospitalization. Estimated GFR was estimated at admission, and patients were grouped according to their GFR (group 1 (
RESULTS RESULTS
The AF incidence in the population was 10%, and it was 8%, 16%, 24% in groups 1, 2, 3, respectively (
CONCLUSIONS CONCLUSIONS
This study demonstrates that new-onset AF incidence during AMI, as well as the associated in-hospital and long-term mortality, increases in parallel with GFR reduction assessed at admission.

Identifiants

pubmed: 32397347
pii: jcm9051396
doi: 10.3390/jcm9051396
pmc: PMC7291027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Centro Cardiologico Monzino, I.R.C.C.S., Milan, Italy
ID : R519/CCM548

Références

Eur Heart J. 2009 Aug;30(16):2019-28
pubmed: 19502623
J Cardiovasc Electrophysiol. 2010 Sep;21(9):983-90
pubmed: 20487120
Am J Cardiol. 2013 Mar 15;111(6):816-22
pubmed: 23273525
Heart Rhythm. 2011 Mar;8(3):342-8
pubmed: 21093611
Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):121-129
pubmed: 29611427
Circulation. 2001 Dec 11;104(24):2886-91
pubmed: 11739301
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
Acta Physiol (Oxf). 2020 Feb;228(2):e13404
pubmed: 31610091
Am J Cardiol. 2003 Nov 1;92(9):1031-6
pubmed: 14583352
Am Heart J. 2015 Mar;169(3):363-70
pubmed: 25728726
Curr Opin Nephrol Hypertens. 2012 Jan;21(1):46-51
pubmed: 22080859
Int J Cardiol. 2011 Jan 7;146(1):28-31
pubmed: 19570585
J Am Coll Cardiol. 1997 Aug;30(2):406-13
pubmed: 9247512
Am J Cardiol. 2009 Jul 15;104(2):169-74
pubmed: 19576341
Eur Heart J. 2009 May;30(9):1038-45
pubmed: 19109347
BMJ. 2015 Feb 03;350:h246
pubmed: 25647223
Heart. 2019 Sep;105(17):1295-1297
pubmed: 31152067
Am J Cardiol. 2003 Nov 15;92(10):1150-4
pubmed: 14609587
Eur Heart J. 2010 Nov;31(22):2755-64
pubmed: 20805110
Am Heart J. 2010 Jun;159(6):1102-7
pubmed: 20569726
Circulation. 2000 Mar 7;101(9):969-74
pubmed: 10704162
Eur J Echocardiogr. 2010 Aug;11(7):602-7
pubmed: 20304839
Heart. 2001 Nov;86(5):527-32
pubmed: 11602545
Eur Heart J. 2005 Feb;26(4):350-6
pubmed: 15618041
Heart. 2008 Jul;94(7):867-73
pubmed: 18332062
N Engl J Med. 2012 Aug 16;367(7):625-35
pubmed: 22894575
Kidney Int. 2015 Jan;87(1):200-9
pubmed: 24897032
Card Electrophysiol Rev. 2003 Sep;7(3):201-7
pubmed: 14739713

Auteurs

Nicola Cosentino (N)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Marco Ballarotto (M)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Jeness Campodonico (J)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Valentina Milazzo (V)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Alice Bonomi (A)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Simonetta Genovesi (S)

Nephrology Unit, San Gerardo Hospital, University of Milan-Bicocca, 20100 Milan, Italy.

Marco Moltrasio (M)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Monica De Metrio (M)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Mara Rubino (M)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Fabrizio Veglia (F)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Emilio Assanelli (E)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Ivana Marana (I)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Marco Grazi (M)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Gianfranco Lauri (G)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Antonio L Bartorelli (AL)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.
Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, 20157 Milan, Italy.

Giancarlo Marenzi (G)

Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy.

Classifications MeSH